Email Alert | RSS

北京大学学报（医学版） ›› 2021, Vol. 53 ›› Issue (4): 811-813. doi: 10.19723/j.issn.1671-167X.2021.04.033

• 病例报告 • 上一篇    下一篇

肾移植术后双侧乳头状肾癌1例

洪鹏1,田晓军1,赵小钰1,杨飞龙1,刘茁1,陆敏2,赵磊1,Δ(),马潞林1,Δ()   

  1. 1.北京大学第三医院 泌尿外科, 北京 100191
    2.北京大学第三医院 病理科,北京 100191
  • 收稿日期:2021-03-14 出版日期:2021-08-18 发布日期:2021-08-25
  • 通讯作者: 赵磊,马潞林 E-mail:bysyzhaolei@163.com;malulin@medmail.com.cn
  • 基金资助:
    北京大学第三医院临床重点项目(BYSYZD2019032)

Bilateral papillary renal cell carcinoma following kidney transplantation: A case report

HONG Peng1,TIAN Xiao-jun1,ZHAO Xiao-yu1,YANG Fei-long1,LIU Zhuo1,LU Min2,ZHAO Lei1,Δ(),MA Lu-lin1,Δ()   

  1. 1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Pathology, Peking University Third Hospital, Beijing 100191, China
  • Received:2021-03-14 Online:2021-08-18 Published:2021-08-25
  • Contact: Lei ZHAO,Lu-lin MA E-mail:bysyzhaolei@163.com;malulin@medmail.com.cn
  • Supported by:
    Key Clinical Projects of Peking University Third Hospital(BYSYZD2019032)

RICH HTML

   

PDF (PC)

关键词: 肾移植, 双侧肾癌, 乳头状肾癌, 手术治疗

Abstract:

With the continuous development of kidney transplantation technique, the survival time after kidney transplantation is gradually prolonged. Thus, the malignant tumor has been the important influencing factor on the long-term survival for kidney transplantation patients. Renal cell carcinoma is a relatively common tumor after kidney transplantation. Besides, clear cell renal cell carcinoma and papillary renal cell carcinoma are the relatively common pathological types for renal cell carcinoma following kidney transplantation. However, bilateral renal cell carcinoma following kidney transplantation is comparatively rare. In this article, we presented a case of bilateral papillary renal cell carcinoma, which occurred after kidney transplantation. And the diagnosis and treatment were introduced in detail. The patient was 37 years old, and he underwent kidney transplantation 13 years ago in our hospital, because of kidney failure. After kidney transplantation, he had regular medical check-up every year. In this year, his urological ultrasound results indicated bilateral renal tumors. And then, he received abdominal and pelvic computed tomography, and the result also showed bilateral renal tumors, which were likely to be malignant tumors. After adequate consultation, the patient chose surgical treatment. The patient received long-term immunosuppressive therapy, because of kidney transplantation. Considering this, the surgeon decided to choose a staging surgical treatment, in order to reduce the bad influence of one-stage surgery. Then, the patient first underwent retroperitoneal laparoscopic radical nephrectomy for right renal tumor in our hospital, and he had no complications after operation. The pathological results showed papillary renal cell carcinoma. He was discharged successfully. He underwent retroperitoneal laparoscopic radical nephrectomy for left renal tumor in our hospital one month later, and he had no complications after operation. The pathological results also showed papillary renal cell carcinoma. He was discharged successfully two days after surgery. In the 3-month follow-up, the patient was recovering well. To sum up, the incidence of bilateral renal cell carcinoma following kidney transplantation is relatively rare, and bilateral radical nephrectomy is effective and safe treatment. Above all, it is the patient’s condition that determines the choice of staging surgery or simultaneous surgery.

Key words: Kidney transplantation, Bilateral renal cell carcinoma, Papillary renal cell carcinoma, Surgical treatment

中图分类号: 

  • R737.11

图1

双肾肾癌CT图"

[1] Briggs JD. Causes of death after renal transplantation [J]. Nephrol Dial Transplant, 2001, 16(8):1545-1549.
doi: 10.1093/ndt/16.8.1545
[2] Végso G, Tóth M, Hídvégi M, et al. Malignancies after renal transplantation during 33 years at a single center [J]. Pathol Oncol Res, 2007, 13(1):63-69.
doi: 10.1007/BF02893443
[3] Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States [J]. Am J Transplant, 2004, 4(6):905-913.
doi: 10.1111/ajt.2004.4.issue-6
[4] Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit [J]. Am J Transplant, 2010, 10(8):1889-1896.
doi: 10.1111/j.1600-6143.2010.03181.x pmid: 20659094
[5] Engels EA, Pfeiffer RM, Fraumeni JF, et al. Spectrum of cancer risk among US solid organ transplant recipients [J]. JAMA, 2011, 306(17):1891-1901.
doi: 10.1001/jama.2011.1592 pmid: 22045767
[6] 张健, 马麟麟, 解泽林, 等. 我国肾移植术后新发恶性肿瘤总结分析 [J]. 中华器官移植杂志, 2014, 35(12):705-710.
[7] Karami S, Yanik EL, Moore LE, et al. Risk of renal cell carcinoma among kidney transplant recipients in the United States [J]. Am J Transplant, 2016, 16(12):3479-3489.
doi: 10.1111/ajt.13862 pmid: 27160653
[8] Apel H, Walschburger-Zorn K, Häberle L, et al. De novo malignancies in renal transplant recipients: experience at a single center with 1 882 transplant patients over 39 yr [J]. Clin Transplant, 2013, 27(1):E30-E36.
doi: 10.1111/ctr.2013.27.issue-1
[9] Choyke PL. Acquired cystic kidney disease [J]. Eur Radiol, 2000, 10(12):1716-1721.
doi: 10.1007/s003300000601
[10] Hoshida Y, Nakanishi H, Shin M, et al. Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations [J]. Transplantation, 1999, 68(3):385-390.
pmid: 10459542
[11] Leveridge M, Musquera M, Evans A, et al. Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients [J]. J Urol, 2011, 186(1):219-223.
doi: 10.1016/j.juro.2011.03.032 pmid: 21575970
[12] Ishikawa I, Honda R, Yamada Y, et al. Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients [J]. Ther Apher Dial, 2004, 8(6):468-473.
pmid: 15663546
[13] Klatte T, Seitz C, Waldert M, et al. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients [J]. BJU Int, 2010, 105(9):1260-1265.
doi: 10.1111/bju.2010.105.issue-9
[14] Gigante M, Neuzillet Y, Patard JJ, et al. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities [J]. BJU Int, 2012, 110(11Pt B):E570-E573.
doi: 10.1111/bju.2012.110.issue-11b
[15] Wang B, Gong H, Zhang X, et al. Bilatetal synchronous sporadic renal cell carcinoma: retroperitoneoscopic strategies and intermediate outcomes of 60 patients [J]. PLoS One, 2016, 11(5):e154578.
[16] Rothman J, Crispen PL, Wong YN, et al. Pathologic concordance of sporadic synchronous bilateral renal mases [J]. Urology, 2008, 72(1):138-142.
doi: 10.1016/j.urology.2008.01.043 pmid: 18336882
[17] Becker F, Siemer S, Tzavaras A, et al. Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment [J]. Urology, 2008, 72(2):349-353.
doi: 10.1016/j.urology.2008.04.001 pmid: 18485459
[18] Lowrance WT, Yee DS, Maschino AC, et al. Developments in the surgical management of sporadic synchronous bilateral renal tumours [J]. BJU Int, 2010, 105(8):1093-1097.
doi: 10.1111/j.1464-410X.2009.08844.x pmid: 19751262
[1] 丁汉东, 王琴, 廖贵益, 郝宗耀. 肾移植术后并发消化道出血的诊治[J]. 北京大学学报（医学版）, 2024, 56(5): 902-907.
[2] 杨文博,余磊,张维宇,徐涛,王强. 带线输尿管支架自排技术在肾移植受者中的效果及安全性[J]. 北京大学学报（医学版）, 2024, 56(4): 656-660.
[3] 陈斌,吴超,刘彬,于涛,王振宇. 脊髓髓内海绵状血管瘤患者不同治疗方式的预后[J]. 北京大学学报（医学版）, 2023, 55(4): 652-657.
[4] 王薇,蔡林,高莹,郭晓蕙,张俊清. 原发性醛固酮增多症术后持续性重度高钾血症1例[J]. 北京大学学报（医学版）, 2022, 54(2): 376-380.
[5] 李秋钰,程秦,赵志伶,代妮妮,曾琳,朱兰,郭炜,李超,王军红,李姝,葛庆岗,沈宁. 肾移植术后感染新型冠状病毒1例[J]. 北京大学学报（医学版）, 2020, 52(4): 780-784.
[6] 赵磊,张洪宪,侯小飞,刘磊,陆敏,韩永,马潞林. 来氟米特联合羟苯磺酸钙治疗肾移植术后BK病毒相关性肾病[J]. 北京大学学报（医学版）, 2020, 52(2): 385-389.
[7] 杨洁,张然,刘宇楠,王佃灿. 表现为耳后区巨大肿物的口外型舌下腺囊肿1例[J]. 北京大学学报（医学版）, 2020, 52(1): 193-195.
[8] 马凯,曲星珂,许清泉,熊六林,叶雄俊,安立哲,陈伟男,黄晓波. 肾移植术后移植肾输尿管膀胱吻合口狭窄的腔内治疗:13例报道[J]. 北京大学学报（医学版）, 2019, 51(6): 1155-1158.
[9] 唐琦,林榕城,姚林,张争,郝瀚,张崔建,蔡林,李学松,何志嵩,周利群. 肾癌术后局部复发患者的临床病理特征及预后分析[J]. 北京大学学报（医学版）, 2019, 51(4): 628-631.
[10] 邱敏，邓绍晖，侯小飞，卢剑，陆敏，刘可，张树栋，马潞林. 腹腔镜膀胱全切及回肠膀胱术治疗女性肾移植术后膀胱癌的可行性[J]. 北京大学学报(医学版), 2018, 50(5): 945-封三.
[11] 郝一昌，侯小飞，赵磊，肖春雷，刘茁，张帆，马潞林. 全腹腔镜移植输尿管膀胱再植术处理肾移植术后输尿管狭窄[J]. 北京大学学报(医学版), 2018, 50(4): 705-710.
[12] 赵磊, 马潞林, 张洪宪, 侯小飞, 刘磊, 付燕, 寇允更, 宋一萌. 后腹腔镜活体供肾切取193例[J]. 北京大学学报(医学版), 2017, 49(5): 867-871.
[13] 张洪宪，赵磊，马潞林，侯小飞，刘磊，邓绍辉. 后腹腔镜供肾切取自体肾移植术治疗复杂医源性输尿管损伤[J]. 北京大学学报(医学版), 2016, 48(4): 622-626.
[14] 刘余庆, 卢剑, 赵磊, 侯小飞, 马潞林. 肾移植受者上尿路尿路上皮癌术后膀胱复发的预后因素[J]. 北京大学学报(医学版), 2015, 47(4): 605-610.
[15] 刘磊, 马潞林, 赵磊, 张洪宪, 侯小飞. 肾移植术后移植肾输尿管狭窄的危险因素分析及手术治疗[J]. 北京大学学报（医学版）, 2014, 46(4): 548-551.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部